fda compounding semaglutide crackdown news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Takes Aim at Hims

Pancreatitis Inflammation of the pancreas is a severe complication related to GLP-1 medicines

There will be days when your diet is better than others, and thats okay

Before this past spring, many compounding pharmacies were selling copycat versions of GLP-1s, which the FDA permits if a drug is in shortage

consumers should verify current status directly at legitscript.com before enrollment Medical group on record - OpenLoop Healthcare Partners, PC - is an established telehealth medical group with publicly posted telehealth consent, SOC 2 certification (via Vanta), and a verifiable address at 317 6th Ave Ste 400, Des Moines, IA 50309 Refund policy, Terms of Use, and telehealth consent are all publicly accessible on the official website Cancellation process is documented and clear iOS and Android apps are publicly available in app stores Contact information for support is published and functional "Prescription medications require a virtual consultation and approval by a licensed healthcare provider" - brand disclaimer is present and accurate What requires direct buyer verification: Specific terms of the "Weight Loss Money Back Guarantee" - contact [email protected] before enrolling Name and accreditation status of the specific compounding pharmacy fulfilling your prescription Exact medication name, dosage, and titration protocol for your program tier What is bundled vs

People also report feeling extremely lethargic, fainting episodes, gas and belching and a general feeling of malaise

By 2030 the impact of widespread use on addressing the global Obesity crisis should be apparent